Background
Patients and methods
Study design
Definitions
Data collection
PaO2/FiO2 determination
Statistical analysis
Results
Characteristics of hypoxemic patients
All hypoxemic patients, n = 859 | Mild hypoxemia P/F 201–300 mmHg, n = 440 | Moderate hypoxemia P/F 101–200 mmHg, n = 345 | Severe hypoxemia P/F ≤ 100 mmHg, n = 74 |
p
| |
---|---|---|---|---|---|
Age, years median (IQR) | 64 [53–73] | 65 [54–74] | 65 [53–73] | 58 [47–69] | 0.006 |
Female, N (%) | 273 (31.8) | 142 (32.3) | 109 (31.6) | 22 (29.7) | 0.91 |
Body mass index (n = 844/431/341/72) | 26.1 [22.5–31.1] | 26.1 [22.7–30.9] | 26.0 [22.5–31.0] | 27.0 [22.1–34.4] | 0.83 |
Main diagnosis at ICU admission (n = 858/439/345/74) | – | ||||
Septic shock | 124 (14.5) | 67 (15.2) | 49 (14.2) | 8 (10.8) | |
Other shock | 47 (5.5) | 24 (5.4) | 17 (4.9) | 6 (8.1) | |
Severe trauma | 20 (2.3) | 14 (3.2) | 6 (1.7) | 0 (0) | |
De novo acute respiratory failure | 275 (32.0) | 118 (26.9) | 120 (34.8) | 37 (50.0) | |
Acute on chronic respiratory failure | 128 (14.9) | 55 (12.5) | 68 (19.7) | 5 (6.8) | |
Coma/seizures | 66 (7.7) | 43 (9.8) | 19 (5.5) | 4 (5.4) | |
Metabolic disorders | 18 (2.1) | 11 (2.5) | 6 (1.7) | 1 (1.4) | |
Hepatic failure | 6 (0.7) | 2 (0.5) | 2 (0.6) | 2 (2.7) | |
Cardiac arrest | 30 (3.5) | 15 (3.4) | 12 (3.5) | 3 (4.1) | |
Postoperative surveillance | 96 (11.2) | 64 (14.6) | 31 (9.0) | 1 (1.3) | |
Other | 48 (5.6) | 26 (5.9) | 15 (4.4) | 7 (9.5) | |
Admission category (n = 857/439/344/74) | 0.004 | ||||
Medical | 675 (78.8) | 327 (74.5) | 281 (81.7) | 67 (90.5) | |
Scheduled surgery | 76 (8.9) | 49 (11.1) | 27 (7.8) | 0 (0) | |
Urgent surgery | 92 (10.7) | 53 (12.1) | 32 (9.3) | 7 (9.5) | |
Trauma | 14 (1.6) | 10 (2.3) | 4 (1.2) | 0 (0) | |
SAPS II (n = 832/425/334/73) | 43 [31–57] | 42 [30–56] | 43 [31–57] | 45 [34–61] | 0.32 |
Chronic respiratory disease (obstructive) (n = 855/440/342/73) | 288 (33.7) | 141 (32.1) | 127 (37.1) | 20 (27.4) | 0.16 |
Chronic respiratory disease (restrictive) (n = 855/440/342/73) | 71 (8.3) | 28 (6.4) | 37 (10.8) | 6 (8.2) | 0.08 |
Obstructive sleep apnea syndrome (n = 855/440/342/73) | 71 (8.3) | 36 (8.2) | 29 (8.5) | 6 (8.2) | 0.99 |
Chronic oxygen therapy (n = 855/440/342/73) | 71 (8.3) | 32 (7.3) | 33 (9.7) | 6 (8.2) | 0.49 |
Long-term non-invasive ventilation (n = 855/440/342/73) | 32 (3.7) | 17 (3.9) | 14 (4.1) | 1 (1.4) | 0.68 |
Chronic heart failure (n = 855/440/342/73) | 145 (17.0) | 74 (16.8) | 62 (18.1) | 9 (12.3) | 0.48 |
Chronic kidney failure (n = 855/440/342/73) | 83 (9.7) | 55 (12.5) | 23 (6.7) | 5 (6.9) | 0.02 |
Cirrhosis (n = 855/440/342/73) | 45 (5.3) | 25 (5.7) | 15 (4.4) | 5 (6.9) | 0.54 |
Cancer (n = 855/440/342/73) | 79 (9.2) | 43 (9.8) | 32 (9.4) | 4 (5.5) | 0.50 |
Immunosuppression (n = 853/439/341/73) | 99 (11.6) | 46 (10.5) | 43 (12.6) | 10 (13.7) | 0.55 |
Withholding/withdrawal of treatment the day of the study | 105 (12.2) | 41 (9.3) | 47 (13.6) | 17 (23) | 0.002 |
All hypoxemic patients, n = 859 | Mild hypoxemia, n = 440 | Moderate hypoxemia, n = 345 | Severe hypoxemia, n = 74 |
p
| |
---|---|---|---|---|---|
Pneumonia, N (%) (n = 852/440/339/73) | 453 (53.2) | 189 (43.0) | 204 (60.2) | 60 (82.2) | < 0.001 |
Aspiration (n = 852/440/339/73) | 74 (8.7) | 30 (6.8) | 33 (9.7) | 11 (15.1) | 0.05 |
Acute on chronic respiratory failure (n = 853/440/340/73) | 166 (19.5) | 73 (16.6) | 80 (23.5) | 13 (17.8) | 0.05 |
Cardiogenic pulmonary edema (n = 853/440/340/73) | 127 (14.9) | 64 (14.6) | 51 (15.0) | 12 (16.4) | 0.91 |
Pulmonary embolism (n = 853/440/340/73) | 26 (3.1) | 16 (3.6) | 7 (2.1) | 3 (4.1) | 0.37 |
Thoracic trauma (n = 852/440/339/73) | 21 (2.5) | 9 (2.1) | 11 (3.2) | 1 (1.4) | 0.59 |
Pleural effusion (n = 852/440/339/73) | 192 (22.5) | 99 (22.5) | 77 (22.7) | 16 (21.9) | 0.99 |
Atelectasis (n = 853/440/340/73) | 176 (20.6) | 93 (21.1) | 72 (21.2) | 11 (15.1) | 0.47 |
Pneumothorax (n = 853/440/340/73) | 15 (1.8) | 6 (1.4) | 7 (2.1) | 2 (2.7) | 0.49 |
Fluid overload (n = 853/440/340/73) | 280 (32.8) | 140 (31.8) | 115 (33.8) | 25 (34.3) | 0.81 |
Acute pancreatitis (n = 852/440/339/73) | 22 (2.6) | 14 (3.2) | 6 (1.8) | 2 (2.7) | 0.48 |
Shock, low PvO2 (n = 853/440/340/73) | 110 (12.9) | 42 (9.6) | 48 (14.1) | 20 (27.4) | < 0.001 |
Smoke/toxic inhalation (n = 852/440/339/73) | 5 (0.6) | 1 (0.2) | 3 (0.9) | 1 (1.4) | 0.20 |
Transfusion-related acute lung injury (n = 852/440/339/73) | 44 (5.2) | 32 (7.3) | 9 (2.7) | 3 (4.1) | 0.01 |
Pulmonary vasculitis (n = 852/440/339/73) | 6 (0.7) | 3 (0.7) | 2 (0.6) | 1 (1.4) | 0.66 |
Drowning (n = 851/440/339/72) | 1 (0.1) | 1 (0.2) | 0 (0) | 0 (0) | 1 |
Other (n = 851/440/338/73) | 90 (10.6) | 43 (9.8) | 42 (12.4) | 5 (6.9) | 0.30 |
Number of causes of hypoxemia (n = 853b/440/340/73) | 2 [1–3] | 2 [1–3] | 2 [1–3] | 2 [1–3] | < 0.001 |
Number of causes of hypoxemia (n = 853b/440/340/73) | < 0.001 | ||||
None | 107 (12.5) | 82 (18.6) | 22 (6.5) | 3 (4.1) | |
1 | 230 (27.0) | 110 (25.0) | 100 (29.4) | 20 (27.4) | |
2 | 221 (25.9) | 110 (25.0) | 93 (27.3) | 18 (24.7) | |
3 or more | 295 (34.6) | 138 (31.4) | 125 (36.8) | 32 (43.8) | |
Radiological infiltrates (n = 845/435/337/73) | 583 (69.0) | 257 (59.1) | 260 (77.2) | 66 (90.4) | < 0.001 |
Unilateralc (n = 581/255/260/66) | 176 (30.3) | 85 (33.3) | 81 (31.2) | 10 (15.2) | 0.02 |
Bilateralc (n = 581/255/260/66) | 406 (69.6) | 171 (67.1) | 179 (68.9) | 56 (84.9) | 0.02 |
ARDS | 178 (20.7) | 65 (14.7) | 82 (23.8) | 31 (41.9) | < 0.001 |
All hypoxemic patients, n = 859 | Mild hypoxemia P/F 201–300 mmHg, n = 440 | Moderate hypoxemia P/F 101–200 mmHg, n = 345 | Severe hypoxemia P/F ≤ 100 mmHg, n = 74 |
p
| |
---|---|---|---|---|---|
Respiratory rate (n = 846/432/340/74) | 23 [18–27] | 22 [18–26] | 24 [20–28] | 25 [20–30] | 0.001 |
Arterial blood gases | 749 (87.2) | 368 (83.6) | 311 (90.1) | 70 (94.6) | 0.004 |
pH (n = 745/366/309/70) | 7.41 [7.36–7.46] | 7.42 [7.38–7.45] | 7.41 [7.36–7.46] | 7.38 [7.29–7.45] | 0.007 |
PaCO2 (mmHg) (n = 749/368/311/70) | 41 [36–49] | 40 [35–46] | 43 [38–55] | 45 [39–56] | 0.001 |
PaCO2 > 45 mmHg (n = 749/368/311/70) | 260 (34.7) | 96 (26.1) | 131 (42.1) | 33 (47.1) | < 0.001 |
PaO2 (mmHg) (n = 749/368/311/70) | 78 [66–92] | 84 [73–100] | 74 [64–88] | 65 [56–74] | < 0.001 |
FiO2 (%) (n = 749/368/311/70) | 0.40 [0.33–0.50] | 0.35 [0.30–0.40] | 0.50 [0.40–0.60] | 1 [0.70–1] | < 0.001 |
HCO3-(meq/L) (n = 747/368/309/70) | 26 [23–30] | 26 [22–29] | 27 [23–32] | 26 [23–30] | 0.03 |
Lactates (meq/L) (n = 630/312/257/61) | 1.3 [1.0–1.9] | 1.2 [0.9–1.7] | 1.3 [1.0–1.9] | 1.4 [1.1–2.7] | 0.02 |
Oxygenation modalities, N (%) | < 0.001 | ||||
Ambient air | 14 (1.6) | 11 (2.5) | 3 (0.9) | 0 (0) | |
Low-flow oxygen | 191 (22.2) | 136 (30.9) | 55 (15.9) | 0 (0) | |
High-flow oxygen | 45 (5.2) | 11 (2.5) | 23 (6.7) | 11 (14.9) | |
Non-invasive ventilation | 84 (9.8) | 43 (9.8) | 33 (9.6) | 8 (10.8) | |
Invasive ventilation | 525 (61.2) | 239 (54.3) | 231 (66.9) | 55 (74.3) | |
Ventilator settingsa | |||||
Tidal volume, mL/kg of ideal body weight; median IQR (n = 509/230/225/54) | 6.9 [6.1–7.9] | 7.1 [6.2–8.1] | 6.8 [6.0–7.6] | 6.1 [4.8–6.6] | < 0.001 |
TV ≤ 8 mL/kg of ideal body weight (n = 509/230/225/54) | 393 (77.2) | 165 (71.7) | 178 (79.1) | 50 (92.6) | 0.003 |
PEEP (cmH20) (n = 519/236/229/54) | 6 [5–10] | 5 [5–8] | 7 [5–10] | 10 [8–12] | < 0.001 |
Plateau pressureb (cmH20) (n = 186/66/84/36) | 22.5 [19–27] | 20 [16–24] | 23.5 [20–28] | 25.5 [23–29.5] | < 0.001 |
Driving pressureb (cmH20) (n = 186/66/84/36) | 14 [10–18] | 13 [9–17] | 14 [11–18] | 13 [10–19] | 0.31 |
Adjunctive therapies | |||||
Prone positioning (n = 516/232/230/54) | 22 (4.3) | 3 (1.3) | 13 (5.7) | 6 (11.1) | 0.001 |
Inhaled NO (n = 513/233/226/54) | 19 (3.7) | 3 (1.3) | 9 (4.0) | 7 (13.0) | 0.001 |
Continuous intravenous sedation, N (%) (n = 522/237/231/54) | 321 (61.5) | 121 (51.1) | 159 (68.8) | 41 (75.9) | < 0.001 |
Neuromuscular blocking agents, N (%) (n = 522/237/231/54) | 83 (15.9) | 11 (4.6) | 44 (19.1) | 28 (51.9) | < 0.001 |
Extracorporeal oxygenation, N (%) (n = 522/237/231/54) | 26 (3.0) | 5 (1.1) | 7 (2.0) | 14 (18.9) | < 0.001 |
ICU length of stay (days) (n = 840/431/336/73) | 16 [7–32] | 15 [7–32] | 16 [8–31.5] | 18 [7–37] | 0.89 |
ICU length of stay (days) in ICU survivors (n = 625/342/246/37) | 15 [7–30] | 15 [7–30] | 14 [6.5–30] | 20.5 [9–46.5] | 0.27 |
ICU mortality, N (%) (n = 839/431/335/73) | 225 (26.7) | 92 (21.3) | 96 (28.5) | 37 (50.7) | < 0.001 |
Ambient air, n = 14 | Low-flow oxygen, n = 191 | High-flow oxygen, n = 45 | Non-invasive ventilation, n = 84 | Invasive ventilation, n = 525 |
p
| |
---|---|---|---|---|---|---|
Pneumonia, N (%) (n = 852/14/189/45/83/521) | 3 (21.4) | 62 (32.8) | 34 (75.6) | 37 (44.6) | 317 (60.8) | < 0.001 |
Aspiration (n = 852/14/190/45/83/520) | 0 (0) | 11 (5.8) | 0 (0) | 3 (3.6) | 60 (11.5) | 0.003 |
Acute on chronic respiratory failure (n = 853/14/190/45/83/521) | 0 (0) | 32 (16.8) | 4 (8.9) | 41 (49.4) | 89 (17.1) | < 0.001 |
Cardiogenic pulmonary edema (n = 853/14/190/45/83/521) | 2 (14.3) | 28 (14.7) | 4 (8.9) | 15 (18.1) | 78 (15.0) | 0.75 |
Pulmonary embolism (n = 853/14/190/45/83/521) | 0 (0) | 5 (2.6) | 2 (4.4) | 2 (2.4) | 17 (3.3) | 0.93 |
Thoracic trauma (n = 852/14/190/45/83/520) | 0 (0) | 5 (2.6) | 2 (4.4) | 0 (0) | 14 (2.7) | 0.46 |
Pleural effusion (n = 852/14/189/45/83/521) | 2 (14.3) | 34 (18.0) | 11 (24.4) | 24 (28.9) | 121 (23.2) | 0.3 |
Atelectasis (n = 853/14/190/45/83/521) | 2 (14.3) | 30 (15.8) | 10 (22.2) | 22 (26.5) | 112 (21.5) | 0.27 |
Pneumothorax (n = 853/14/190/45/83/521) | 0 (0) | 4 (2.1) | 0 (0) | 0 (0) | 11 (2.1) | 0.72 |
Fluid overload (n = 853/14/190/45/83/521) | 2 (14.3) | 47 (24.7) | 12 (26.7) | 28 (33.7) | 191 (36.7) | 0.02 |
Acute pancreatitis (n = 852/14/190/45/83/520) | 0 (0) | 6 (3.2) | 0 (0) | 1 (1.2) | 15 (2.9) | 0.81 |
Shock, low PvO2 (n = 853/14/190/45/83/521) | 0 (0) | 6 (3.2) | 3 (6.7) | 6 (7.2) | 95 (18.2) | < 0.001 |
Smoke/toxic inhalation (n = 852/14/190/45/83/520) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 5 (1.0) | 0.63 |
Transfusion-related acute lung injury (n = 852/14/190/45/83/520) | 1 (7.1) | 10 (5.3) | 2 (4.4) | 3 (3.6) | 28 (5.4) | 0.92 |
Pulmonary vasculitis (n = 852/14/190/45/83/520) | 0 (0) | 1 (0.5) | 0 (0) | 0 (0) | 5 (1.0) | 1 |
Drowning (n = 851/14/190/45/82/520) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (0.2) | 1 |
Other (n = 851/14/190/45/83/519) | 0 (0) | 21 (11.1) | 11 (24.4) | 9 (10.8) | 49 (9.4) | 0.04 |
Number of causes of hypoxemia (n = 853/14/190/45/83/521) | 1 [0–1] | 1 [1, 2] | 2 [1, 2] | 2 [1–3] | 2 [1–3] | < 0.001 |
Number of causes of hypoxemia (n = 853/14/190/45/83/521) | < 0.001 | |||||
None | 6 (42.9) | 41 (21.6) | 0 (0) | 6 (7.2) | 54 (10.4) | |
1 | 5 (35.7) | 63 (33.1) | 16 (35.6) | 24 (28.9) | 122 (23.4) | |
2 | 2 (14.3) | 45 (23.7) | 18 (40.0) | 23 (27.7) | 133 (25.5) | |
3 or more | 1 (7.1) | 41 (21.6) | 11 (24.4) | 30 (36.2) | 212 (40.7) | |
Radiological infiltrates (n = 845/14/189/45/82/515) | 4 (28.6) | 101 (53.4) | 37 (82.2) | 57 (69.5) | 384 (74.6) | < 0.001 |
Unilateral c (n = 583/4/101/37/56/385) | 1 (25.0) | 36 (35.6) | 9 (24.3) | 19 (33.9) | 111 (28.8) | 0.58 |
Bilateral c (n = 581/4/100/37/56/384) | 3 (75.0) | 65 (65.0) | 28 (75.7) | 37 (66.1) | 273 (71.1) | 0.65 |
ARDS | 0 (0) | 0 (0) | 0 (0) | 9 (10.7) | 169 (32.2) | < 0.001 |
Hypoxemia class | < 0.001 | |||||
Mild | 11 (78.6) | 136 (71.2) | 11 (24.4) | 43 (51.2) | 239 (45.5) | |
Moderate | 3 (21.4) | 55 (28.8) | 23 (51.2) | 33 (39.3) | 231 (44.0) | |
Severe | 0 (0) | 0 (0) | 11 (24.4) | 8 (9.5) | 55 (10.5) | |
ICU length of stay (days) (n = 840/14/190/45/83/508) | 11 [4–21] | 8 [4–17] | 14 [8–23] | 9 [4–18] | 21 [12–40] | < 0.001 |
ICU length of stay (days) in ICU survivors (n = 625/11/170/37/70/337) | 11 [4–16] | 7.5 [4–15] | 13 [8–22] | 9 [4–18] | 24 [12–43] | < 0.001 |
ICU mortality, N (%) (n = 839/14/190/44/83/508) | 3 (21.4) | 20 (10.5) | 7 (15.9) | 13 (15.7) | 168 (33.1) | < 0.001 |
Ventilator settings in patients on invasive mechanical ventilation
Outcomes
Multivariate analysis
Adjusted HR × [95% CI] |
p
| |
---|---|---|
Age | 1.01 [1.00–1.02] | 0.054 |
Obesity | 0.63 [0.45–0.89] | 0.008 |
Main diagnosis at ICU admission | 0.049 | |
Septic shock | 1.05 [0.68–1.64] | |
Other shock | 1.83 [1.09–3.07] | |
Severe trauma | 0.29 [0.04–2.13] | |
De novo acute respiratory failure | 1 (ref) | |
Acute on chronic respiratory failure | 1.56 [0.95–2.57] | |
Coma/seizures | 1.58 [0.89–2.78] | |
Metabolic disorders | 0.74 [0.25–2.19] | |
Cardiac arrest | 1.73 [0.88–3.40] | |
Postoperative surveillance | 0.67 [0.32–1.40] | |
Other | 0.76 [0.37–1.56] | |
Chronic heart failure | 1.69 [1.19–2.42] | 0.004 |
Chronic kidney failure | 1.65 [1.05–2.62] | 0.032 |
Cirrhosis | 1.71 [0.95–3.10] | 0.075 |
SAPS II (per point) | 1.01 [1.00–1.02] | 0.012 |
Hypoxemia class | < 0.001 | |
Mild | 1 (ref) | |
Moderate | 1.38 [1.00–1.90] | |
Severe | 2.65 [1.69–4.15] |